| Chemogenetic control of gene expression and cell signaling with antiviral drugs EP Tague, HL Dotson, SN Tunney, DC Sloas, JT Ngo Nature methods 15 (7), 519-522, 2018 | 49 | 2018 |
| High-performance multiplex drug-gated CAR circuits HS Li, NM Wong, E Tague, JT Ngo, AS Khalil, WW Wong Cancer Cell 40 (11), 1294-1305. e4, 2022 | 41 | 2022 |
| Engineering clinically-approved drug gated CAR circuits HS Li, NM Wong, E Tague, JT Ngo, AS Khalil, WW Wong Biorxiv, 2020.12. 14.419812, 2020 | 4 | 2020 |
| Controlled protein activities with viral proteases, antiviral peptides, and antiviral drugs EP Tague, JB McMahan, N Tague, MJ Dunlop, JT Ngo ACS chemical biology 18 (5), 1228-1236, 2023 | 3 | 2023 |
| Chimeric antigen receptor (CAR) modulation J Ngo, W Wong, MLN Wong, LI Huishan, EP Tague US Patent 11,059,864, 2021 | 2 | 2021 |
| Drug-controlled systems and uses thereof M DUNLOP, EP TAGUE, NM TAGUE, AM MARZILLI US Patent 11,660,288, 2023 | 1 | 2023 |
| Novel drug-controlled systems and uses thereof M DUNLOP, EP TAGUE, NM TAGUE, AM MARZILLI US Patent App. 18/173,277, 2023 | | 2023 |
| Chimeric antigen receptor (car) modulation J Ngo, W Wong, MLN Wong, LI Huishan, EP Tague US Patent App. 17/343,022, 2022 | | 2022 |
| Engineered extracellular receptor constructs and uses thereof EP Tague, JB MCMAHAN US Patent App. 17/458,739, 2022 | | 2022 |
| Inducible Gene Expression and Protein Localization using CRISPR/DCAS9 and Antiviral Protease Inhibitors EP Tague, J Ngo Biophysical Journal 114 (3), 225a, 2018 | | 2018 |
| Inducible gene expression control using CRISPR/dCas9 and antiviral protease inhibitors E Tague, J Ngo PROTEIN SCIENCE 26, 200-200, 2017 | | 2017 |
